Drug disposition in cystic fibrosis: progress in understanding pathophysiology and pharmacokinetics.

Suppr

超能文献

作者信息

Prandota J

机构信息

J. Korczak Memorial Children's Hospital, Wrocław, Poland.

出版信息

Pediatr Infect Dis J. 1987 Dec;6(12):1111-26.

PMID:3324042

Abstract

摘要

相似文献

Drug disposition in cystic fibrosis: progress in understanding pathophysiology and pharmacokinetics.

Pediatr Infect Dis J. 1987 Dec;6(12):1111-26.

Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.囊性纤维化中抗生素及其他药物的临床药理学

Drugs. 1988 May;35(5):542-78. doi: 10.2165/00003495-198835050-00004.

[Starch malabsorption in pancreatic cystic fibrosis].[胰腺囊性纤维化中的淀粉吸收不良]

Fracastoro. 1970 May-Aug;63(3):399-403.

Small intestinal glucose absorption in cystic fibrosis: a study in human and transgenic DeltaF508 cystic fibrosis mouse tissues.囊性纤维化患者小肠对葡萄糖的吸收：一项针对人类及转基因ΔF508囊性纤维化小鼠组织的研究

J Pharm Pharmacol. 2004 Mar;56(3):329-38. doi: 10.1211/0022357022863.

[Intestinal absorption of sugars in mucoviscidosis].[黏液囊肿纤维化中糖的肠道吸收]

Fracastoro. 1966 May-Jun;59(3):225-41.

[Absorption of fats in cystic fibrosis (mucoviscidosis)].[囊性纤维化（黏液黏稠症）中脂肪的吸收]

Riv Clin Pediatr. 1970 Sep-Oct;83(3):100-7.

Cimetidine and fat malabsorption in children with cystic fibrosis.西米替丁与囊性纤维化患儿的脂肪吸收不良

Helv Paediatr Acta. 1981 Sep;36(4):359-69.

Taurine improves the absorption of a fat meal in patients with cystic fibrosis.

Pediatrics. 1987 Oct;80(4):517-23.

[Intestinal absorption of fats in children using serum turbidity and triglyceride absorption tests].[利用血清浊度和甘油三酯吸收试验对儿童脂肪的肠道吸收情况进行研究]

Arq Gastroenterol. 1985 Oct-Dec;22(4):196-203.

[Intestinal capacity for absorbing D-xylose in patients of pediatric age].[小儿患者肠道对D-木糖的吸收能力]

Bol Med Hosp Infant Mex. 1974 Jan-Feb;31(1):1-15.

引用本文的文献

The Pharmacokinetic Changes in Cystic Fibrosis Patients Population: Narrative Review.囊性纤维化患者群体的药代动力学变化：叙述性综述

Medicines (Basel). 2024 Dec 31;12(1):1. doi: 10.3390/medicines12010001.

A Polyclonal Antibody Raised against the OmpA-like Protein BCAL2645 Impairs the Bacterium Adhesion and Invasion of Human Epithelial Cells In Vitro.一种针对类OmpA蛋白BCAL2645产生的多克隆抗体在体外可削弱该细菌对人上皮细胞的黏附和侵袭。

Biomedicines. 2021 Nov 29;9(12):1788. doi: 10.3390/biomedicines9121788.

Immunization and Immunotherapy Approaches against and Complex Infections.针对寄生虫和复杂感染的免疫接种及免疫治疗方法。

Vaccines (Basel). 2021 Jun 18;9(6):670. doi: 10.3390/vaccines9060670.

Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis.四十年来囊性纤维化患者β-内酰胺类抗生素的药代动力学研究

Clin Pharmacokinet. 2019 Feb;58(2):143-156. doi: 10.1007/s40262-018-0678-x.

Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis.β-内酰胺类药物持续输注治疗成人囊性纤维化急性加重期的药代动力学。

Chest. 2018 Nov;154(5):1108-1114. doi: 10.1016/j.chest.2018.06.002. Epub 2018 Jun 13.

Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers.囊性纤维化患者和健康志愿者中哌拉西林群体药代动力学和药效学的系统比较。

Antimicrob Agents Chemother. 2007 Jul;51(7):2497-507. doi: 10.1128/AAC.01477-06. Epub 2007 May 7.

Drug disposition in cystic fibrosis.囊性纤维化中的药物处置

Clin Pharmacokinet. 1998 Oct;35(4):313-29. doi: 10.2165/00003088-199835040-00004.

Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients.每日一次使用阿米卡星治疗囊性纤维化患者铜绿假单胞菌肺部加重的耐受性、药代动力学及疗效

Eur J Pediatr. 1996 Nov;155(11):948-53. doi: 10.1007/BF02282885.

Abnormal pharmacokinetics: the need for monitoring.

Eur J Clin Microbiol Infect Dis. 1993;12 Suppl 1:S58-60. doi: 10.1007/BF02389880.

Lean body mass as a predictor of drug dosage. Implications for drug therapy.瘦体重作为药物剂量的预测指标。对药物治疗的启示。

Clin Pharmacokinet. 1994 Apr;26(4):292-307. doi: 10.2165/00003088-199426040-00005.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验